Clinical Trial Update: Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the combination of Becotatug Vedotin and Sintilimab for locoregionally advanced nasopharyngeal carcinoma is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Becotatug Vedotin
• Sintilimab (sintilimab)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 3 | Status: RECRUITING